Form D · Pharmaceuticals

United BioSource Corp

Bethesda, MD · CIK 0001301810

Offering snapshot reported Aug 13, 2010 · SEC filing

Reported sold
$37.8K
Indefinite offering
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 4, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 13, 2010Initial$37,800No comparison2SEC filing
Jun 10, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 10, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 10, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 10, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 10, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Apr 25, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 20, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Mar 10, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
Yes
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-146416

Source: Form D, filed Aug 13, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Frank A. Adams Director
Peter Castleman Director
Mark P. Clein Director, Executive
Jesse Glossner Executive
Harris Hyman, Iv Director
Ann H. Lamont Director
Ethan D. Leder Director, Executive
John B. Mariano, Jr. Executive
Micah Meisel Director
D. Randolph Peeler Director
Rita Sahni Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
7501 Wisconsin Avenue, Suite 705
Bethesda, MD, 20814